Matches in SemOpenAlex for { <https://semopenalex.org/work/W3032605714> ?p ?o ?g. }
Showing items 1 to 63 of
63
with 100 items per page.
- W3032605714 endingPage "8" @default.
- W3032605714 startingPage "S3" @default.
- W3032605714 abstract "Everolimus, a novel proliferation signal inhibitor initially developed for the prevention of allograft rejection after organ transplantation, is a potent anti-proliferative and immunosuppressive agent. Compared to sirolimus, everolimus absorbs to local tissue more rapidly and possesses longer cellular residence time and activity. The stent-based intracoronary elution of everolimus was first investigated by BioSensors International using a bioabsorbable-PLA-polymer-coated S-Stent for drug delivery. Following preclinical animal studies that demonstrated excellent safety and efficacy of this device, the clinical FUTURE trial program was initiated. FUTURE I and II were designed to demonstrate safety and feasibility of the everolimus-eluting stent in a small patient population with focal de novo coronary lesions. At follow-up, an acceptable safety profile without evidence of stent thrombosis or late stent malapposition was observed. Moreover, these studies revealed a remarkable reduction of neointimal proliferation with everolimus-eluting stent implantation versus procedures utilizing bare-metal stents. Guidant Corporation licensed the exclusive rights to both the S-Stent and the bioabsorbable drug delivery platform. Guidant will conduct two pivotal trials (FUTURE III and IV) in order to demonstrate the efficacy of this stent design. FUTURE IV will make a non-inferiority comparison between everolimus and the already-approved drug eluting stent systems. Given the pooled results of FUTURE I and II, there is already some evidence suggesting that the everolimus-eluting stent is as potent a suppressor of reactive neointimal ingrowth as the sirolimus-eluting CYPHERTM stent. The everolimus-eluting coronary stent might shortly be established as a new and promising contender in the field of drug eluting stents for treatment of coronary heart disease." @default.
- W3032605714 created "2020-06-05" @default.
- W3032605714 creator A5018800965 @default.
- W3032605714 creator A5052330266 @default.
- W3032605714 date "2004-01-01" @default.
- W3032605714 modified "2023-09-23" @default.
- W3032605714 title "Everolimus for stent-based intracoronary applications." @default.
- W3032605714 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15184828" @default.
- W3032605714 hasPublicationYear "2004" @default.
- W3032605714 type Work @default.
- W3032605714 sameAs 3032605714 @default.
- W3032605714 citedByCount "11" @default.
- W3032605714 countsByYear W30326057142012 @default.
- W3032605714 countsByYear W30326057142013 @default.
- W3032605714 countsByYear W30326057142015 @default.
- W3032605714 countsByYear W30326057142018 @default.
- W3032605714 crossrefType "journal-article" @default.
- W3032605714 hasAuthorship W3032605714A5018800965 @default.
- W3032605714 hasAuthorship W3032605714A5052330266 @default.
- W3032605714 hasConcept C126322002 @default.
- W3032605714 hasConcept C2777921159 @default.
- W3032605714 hasConcept C2778283817 @default.
- W3032605714 hasConcept C2778583881 @default.
- W3032605714 hasConcept C2779699572 @default.
- W3032605714 hasConcept C2780911114 @default.
- W3032605714 hasConcept C71924100 @default.
- W3032605714 hasConceptScore W3032605714C126322002 @default.
- W3032605714 hasConceptScore W3032605714C2777921159 @default.
- W3032605714 hasConceptScore W3032605714C2778283817 @default.
- W3032605714 hasConceptScore W3032605714C2778583881 @default.
- W3032605714 hasConceptScore W3032605714C2779699572 @default.
- W3032605714 hasConceptScore W3032605714C2780911114 @default.
- W3032605714 hasConceptScore W3032605714C71924100 @default.
- W3032605714 hasLocation W30326057141 @default.
- W3032605714 hasOpenAccess W3032605714 @default.
- W3032605714 hasPrimaryLocation W30326057141 @default.
- W3032605714 hasRelatedWork W1524803505 @default.
- W3032605714 hasRelatedWork W1989556574 @default.
- W3032605714 hasRelatedWork W1998512403 @default.
- W3032605714 hasRelatedWork W2029461054 @default.
- W3032605714 hasRelatedWork W2037994972 @default.
- W3032605714 hasRelatedWork W2040581079 @default.
- W3032605714 hasRelatedWork W2042024641 @default.
- W3032605714 hasRelatedWork W2061316537 @default.
- W3032605714 hasRelatedWork W2074384350 @default.
- W3032605714 hasRelatedWork W2079818105 @default.
- W3032605714 hasRelatedWork W2083630382 @default.
- W3032605714 hasRelatedWork W2096568100 @default.
- W3032605714 hasRelatedWork W2101281919 @default.
- W3032605714 hasRelatedWork W2119785324 @default.
- W3032605714 hasRelatedWork W2131308249 @default.
- W3032605714 hasRelatedWork W2211767592 @default.
- W3032605714 hasRelatedWork W2474105275 @default.
- W3032605714 hasRelatedWork W2765404546 @default.
- W3032605714 hasRelatedWork W2891695063 @default.
- W3032605714 hasRelatedWork W3146938078 @default.
- W3032605714 hasVolume "5 Suppl 2" @default.
- W3032605714 isParatext "false" @default.
- W3032605714 isRetracted "false" @default.
- W3032605714 magId "3032605714" @default.
- W3032605714 workType "article" @default.